Estrous cycle regulation of extrasynaptic δ-containing GABA(A) receptor-mediated tonic inhibition and limbic epileptogenesis

J Pharmacol Exp Ther. 2013 Jul;346(1):146-60. doi: 10.1124/jpet.113.203653. Epub 2013 May 10.

Abstract

The ovarian cycle affects susceptibility to behavioral and neurologic conditions. The molecular mechanisms underlying these changes are poorly understood. Deficits in cyclical fluctuations in steroid hormones and receptor plasticity play a central role in physiologic and pathophysiologic menstrual conditions. It has been suggested that synaptic GABA(A) receptors mediate phasic inhibition in the hippocampus and extrasynaptic receptors mediate tonic inhibition in the dentate gyrus. Here we report a novel role of extrasynaptic δ-containing GABA(A) receptors as crucial mediators of the estrous cycle-related changes in neuronal excitability in mice, with hippocampus subfield specificity. In molecular and immunofluorescence studies, a significant increase occurred in δ-subunit, but not α4- and γ2-subunits, in the dentate gyrus during diestrus. However, δ-subunit upregulation was not evident in the CA1 region. The δ-subunit expression was undiminished by age and ovariectomy and in mice lacking progesterone receptors, but it was significantly reduced by finasteride, a neurosteroid synthesis inhibitor. Electrophysiologic studies confirmed greater potentiation of GABA currents by progesterone-derived neurosteroid allopregnanolone in dissociated dentate gyrus granule cells in diestrus than in CA1 pyramidal cells. The baseline conductance and allopregnanolone potentiation of tonic currents in dentate granule cells from hippocampal slices were higher than in CA1 pyramidal cells. In behavioral studies, susceptibility to hippocampus kindling epileptogenesis was lower in mice during diestrus. These results demonstrate the estrous cycle-related plasticity of neurosteroid-sensitive, δ-containing GABA(A) receptors that mediate tonic inhibition and seizure susceptibility. These findings may provide novel insight on molecular cascades of menstrual disorders like catamenial epilepsy, premenstrual syndrome, and migraine.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • 5-alpha Reductase Inhibitors / pharmacology
  • Animals
  • Behavior, Animal
  • CA1 Region, Hippocampal / cytology
  • CA1 Region, Hippocampal / drug effects
  • CA1 Region, Hippocampal / metabolism
  • CA1 Region, Hippocampal / pathology
  • Dentate Gyrus / cytology
  • Dentate Gyrus / drug effects
  • Dentate Gyrus / metabolism*
  • Dentate Gyrus / pathology
  • Disease Susceptibility
  • Epilepsy / blood
  • Epilepsy / etiology*
  • Epilepsy / metabolism
  • Epilepsy / pathology
  • Estrous Cycle*
  • Female
  • GABAergic Neurons / cytology
  • GABAergic Neurons / drug effects
  • GABAergic Neurons / metabolism*
  • GABAergic Neurons / pathology
  • Gene Expression Regulation
  • In Vitro Techniques
  • Kindling, Neurologic
  • Mice
  • Mice, Knockout
  • Nerve Tissue Proteins / biosynthesis
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism*
  • Neural Inhibition* / drug effects
  • Neuronal Plasticity
  • Pregnanolone / metabolism
  • Progesterone / blood
  • Protein Subunits / metabolism
  • Receptors, GABA-A / biosynthesis
  • Receptors, GABA-A / genetics
  • Receptors, GABA-A / metabolism*
  • Receptors, Progesterone / genetics
  • Receptors, Progesterone / metabolism

Substances

  • 5-alpha Reductase Inhibitors
  • Gabrd protein, mouse
  • Nerve Tissue Proteins
  • Protein Subunits
  • Receptors, GABA-A
  • Receptors, Progesterone
  • Progesterone
  • Pregnanolone